Experiments performed in MHC class I knockouts and CD8+ T cell antibody-depleted mice substantially reduced the anti-tumor effects of the vaccine thereby supporting the essential role of CD8+ T cells in this model. This evidence concerns the gene CD8A and neoplasm.